Literature DB >> 4542807

Cytotoxic thymus-derived lymphocytes in cerebrospinal fluid of mice with lymphocytic choriomeningitis.

R M Zinkernagel, P C Doherty.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4542807      PMCID: PMC2139441          DOI: 10.1084/jem.138.5.1266

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


× No keyword cloud information.
  6 in total

1.  Intracerebral injections and the growth of viruses in the mouse brain.

Authors:  C A MIMS
Journal:  Br J Exp Pathol       Date:  1960-02

2.  Requirement for theta-bearing cells in lymphocytic choriomeningitis virus-induced central nervous system disease.

Authors:  G A Cole; N Nathanson; R A Prendergast
Journal:  Nature       Date:  1972-08-11       Impact factor: 49.962

3.  Cell-mediated immunity to bacterial infection in the mouse. Thymus-derived cells as effectors of acquired resistance to Listeria monocytogenes.

Authors:  R V Blanden; R E Langman
Journal:  Scand J Immunol       Date:  1972       Impact factor: 3.487

4.  Antiviral action of immune lymphocytes in mice infected with lymphocytic choriomeningitis virus.

Authors:  C A Mims; R V Blanden
Journal:  Infect Immun       Date:  1972-11       Impact factor: 3.441

5.  Studies on cell-mediated immunity to lymphocytic choriomeningitis virus in mice.

Authors:  O Marker; M Volkert
Journal:  J Exp Med       Date:  1973-06-01       Impact factor: 14.307

6.  Immunopathogenesis of acute central nervous system disease produced by lymphocytic choriomeningitis virus. I. Cyclophosphamide-mediated induction by the virus-carrier state in adult mice.

Authors:  D H Gilden; G A Cole; A A Monjan; N Nathanson
Journal:  J Exp Med       Date:  1972-04-01       Impact factor: 14.307

  6 in total
  35 in total

Review 1.  The early history of B cells.

Authors:  Max D Cooper
Journal:  Nat Rev Immunol       Date:  2015-02-06       Impact factor: 53.106

2.  Treatment of mice with polyinosinic-polycytidilic polyribonucleotide reduces T-cell involvement in a localized inflammatory response to vaccinia virus challenge.

Authors:  R Korngold; P C Doherty
Journal:  J Virol       Date:  1985-02       Impact factor: 5.103

3.  Meningeal exudate cells in vaccinia meningitis of mice: role of local T cells.

Authors:  T Morishima; K Hayashi
Journal:  Infect Immun       Date:  1978-06       Impact factor: 3.441

4.  Influenzal pneumonia: early appearance of cross-reactive T cells in lungs of mice primed with heterologous type A viruses.

Authors:  J Bennink; R B Effros; P C Doherty
Journal:  Immunology       Date:  1978-09       Impact factor: 7.397

5.  Vaccination against persistent viral infection exacerbates CD4+ T-cell-mediated immunopathological disease.

Authors:  D Hildeman; D Yañez; K Pederson; T Havighurst; D Muller
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

6.  Monoclonal antibody-defined immunoregulatory cells in multiple sclerosis cerebrospinal fluid.

Authors:  N Cashman; C Martin; J F Eizenbaum; J D Degos; M A Bach
Journal:  J Clin Invest       Date:  1982-08       Impact factor: 14.808

7.  The permeability of the blood-brain barrier in mice suffering from fatal lymphocytic choriomeningitis virus infection.

Authors:  O Marker; M H Nielsen; N H Diemer
Journal:  Acta Neuropathol       Date:  1984       Impact factor: 17.088

8.  Cytotoxic T cells are induced in mice infected with lymphocytic choriomeningitis virus strains of markedly different pathogenicities.

Authors:  C J Pfau; J K Valenti; S Jacobson; D C Pevear
Journal:  Infect Immun       Date:  1982-05       Impact factor: 3.441

9.  Lymphocytic choriomeningitis infection in the nude mouse. An immunopathological study.

Authors:  P Ronco; Y Rivière; Y Thoua; M T Bandu; J C Guillon; P Verroust; L Morel-Maroger
Journal:  Immunology       Date:  1981-08       Impact factor: 7.397

10.  Dual nature of the adaptive immune system in lampreys.

Authors:  Peng Guo; Masayuki Hirano; Brantley R Herrin; Jianxu Li; Cuiling Yu; Andrea Sadlonova; Max D Cooper
Journal:  Nature       Date:  2009-05-27       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.